
BENLYSTA (Belimumab)
BENLYSTA (belimumab) is indicated for the treatment of: patients aged 5 years and older with active systemic lupus erythematosus (SLE) who are receiving standard therapy, and …
BENLYSTA (belimumab) is indicated for the treatment of: patients aged 5 years and older with active systemic lupus erythematosus (SLE) who are receiving standard therapy, and …
BLENREP is indicated for the treatment of adults with relapsed or refractory multiple myeloma who have received at least 4 prior therapies, including an anti-CD38 monoclonal antibody, a…
BREO ELLIPTA is a combination of fluticasone furoate, a corticosteroid, and vilanterol, a long-acting beta 2 -adrenergic agonist (LABA), indicated for: the maintenance treatment of…
COREG is an alpha-/beta-adrenergic blocking agent indicated for the treatment of: mild to severe chronic heart failure (1.1) left ventricular dysfunction following myocardial…
COREG CR is an alpha-/beta-adrenergic blocking agent indicated for the treatment of: mild to severe chronic heart failure. (1.1) left ventricular dysfunction following myocardial…
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2023. All Rights Reserved.